BSX Boston Scientific
NYSE · SEC CIK 885725 · EDGAR
- Bought, last 12 months
- $10.04M 8 purchases by 5 insiders
- Sold, last 12 months
- $29.27M 6 sales by 4 insiders
- Filings on record
- 526 since 2021-07-06, latest 2026-09-03 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| Zane Ellen M | Dir | — | $2.57M |
| Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| LUDWIG EDWARD J | Dir | $430.3K | — |
| Habiger David C | Dir | $407.9K | — |
| Morano Susan E | Dir | $100.4K | — |
| Pegus Cheryl | Dir | $100.0K | — |
| O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 847
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-03 | 2025-06-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $103.69 | -164.4K | 1.57M | -9% | -$17.05M |
| DM | 2025-06-03 | 2025-06-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.64M | +7% | +$2.18M |
| 2025-05-30 | 2025-05-29 | BSX | LUDWIG EDWARD J | Dir | S - Sale | $104.59 | -4,000 | 22.5K | -15% | -$418.4K | |
| 2025-05-22 | 2025-05-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $106.42 | -4,826 | 31.4K | -13% | -$513.6K | |
| 2025-05-09 | 2025-05-08 | BSX | FUJIMORI YOSHIAKI | Dir | A - Grant | $0.00 | +2,081 | 4,982 | +72% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | Habiger David C | Dir | A - Grant | $0.00 | +2,081 | 5,628 | +59% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | Sununu John E | Dir | A - Grant | $0.00 | +2,081 | 54.7K | +4% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | LUDWIG EDWARD J | Dir | A - Grant | $0.00 | +2,081 | 26.5K | +9% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | WICHMANN DAVID S | Dir | A - Grant | $0.00 | +2,081 | 41.6K | +5% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | Mega Jessica L | Dir | A - Grant | $0.00 | +2,081 | 8,235 | +34% | $0 | |
| 2025-05-09 | 2025-05-08 | BSX | Zane Ellen M | Dir | A - Grant | $0.00 | +2,081 | 37.0K | +6% | $0 | |
| M | 2025-05-09 | 2025-05-08 | BSX | Morano Susan E | Dir | A - Grant | $0.00 | +2,686 | 6,034 | +80% | $0 |
| D | 2025-05-06 | 2025-05-02 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +2,102 | 24.3K | +9% | $0 |
| D | 2025-05-06 | 2025-05-02 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $104.93 | -1,017 | 23.3K | -4% | -$106.7K |
| D | 2025-05-06 | 2025-05-02 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +4,204 | 25.2K | +20% | $0 |
| D | 2025-05-06 | 2025-05-05 | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale+OE | $104.54 | -4,572 | 18.7K | -20% | -$478.0K |
| D | 2025-05-06 | 2025-05-02 | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $104.93 | -1,918 | 23.3K | -8% | -$201.3K |
| D | 2025-05-05 | 2025-05-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $102.06 | -17.3K | 22.2K | -44% | -$1.77M |
| DM | 2025-05-05 | 2025-05-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $24.81 | +17.3K | 35.4K | +96% | +$429.5K |
| DM | 2025-05-05 | 2025-05-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $102.48 | -164.4K | 1.63M | -9% | -$16.85M |
| DM | 2025-05-05 | 2025-05-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.65M | +7% | +$2.18M |
| 2025-04-22 | 2025-04-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $95.09 | -4,826 | 36.2K | -12% | -$458.9K | |
| D | 2025-04-02 | 2025-04-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $100.01 | -164.4K | 1.59M | -9% | -$16.45M |
| DM | 2025-04-02 | 2025-04-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.71M | +7% | +$2.18M |
| 2025-03-24 | 2025-03-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $100.85 | -4,826 | 41.0K | -11% | -$486.7K | |
| D | 2025-03-05 | 2025-03-03 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $37.50 | +5,949 | 8,063 | +281% | +$223.1K |
| DM | 2025-03-05 | 2025-03-03+ | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale+OE | $104.95 | -7,631 | 432 | -95% | -$800.9K |
| DM | 2025-03-03 | 2025-02-28+ | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $37.78 | +8,055 | 11.5K | +233% | +$304.3K |
| D | 2025-03-03 | 2025-02-28 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale+OE | $101.13 | -9,887 | 1,632 | -86% | -$999.9K |
| D | 2025-03-03 | 2025-03-01 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $103.79 | -355 | 2,114 | -14% | -$36.8K |
| M | 2025-02-26 | 2025-02-24+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -2,040 | 178.3K | -1% | $0 |
| I | 2025-02-26 | 2025-02-24 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +340 | 5,234 | +7% | $0 |
| M | 2025-02-25 | 2025-02-24+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $104.16 | -7,363 | 25.8K | -22% | -$766.9K |
| 2025-02-24 | 2025-02-24 | BSX | Zane Ellen M | Dir | S - Sale | $104.23 | -13.6K | 34.9K | -28% | -$1.42M | |
| 2025-02-21 | 2025-02-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $104.64 | -4,826 | 45.8K | -10% | -$505.0K | |
| 2025-02-21 | 2025-02-20 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -1,000 | 180.4K | -0.6% | $0 | |
| M | 2025-02-19 | 2025-02-18+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale | $104.84 | -5,960 | 21.0K | -22% | -$624.9K |
| DM | 2025-02-19 | 2025-02-19 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $25.61 | +60.5K | 283.7K | +27% | +$1.55M |
| DM | 2025-02-19 | 2025-02-18+ | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.10 | -84.9K | 232.6K | -27% | -$8.92M |
| 2025-02-19 | 2025-02-19 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.35 | -1,510 | 33.1K | -4% | -$159.1K | |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +51.1K | 1.64M | +3% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $106.11 | -24.7K | 1.65M | -1% | -$2.62M |
| DM | 2025-02-18 | 2025-02-14+ | BSX | O'Sullivan Miriam | SVP, Chief HR Off | M - OptEx | $0.00 | +3,113 | 15.1K | +26% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | O'Sullivan Miriam | SVP, Chief HR Off | F - Tax | $106.11 | -915 | 14.8K | -6% | -$97.1K |
| DMI | 2025-02-18 | 2025-02-14+ | BSX | O'Sullivan Miriam | SVP, Chief HR Off | M - OptEx | $0.00 | +291 | 1,767 | +20% | $0 |
| DMI | 2025-02-18 | 2025-02-14+ | BSX | O'Sullivan Miriam | SVP, Chief HR Off | F - Tax | $106.11 | -104 | 1,731 | -6% | -$11.0K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $106.11 | -4,142 | 34.6K | -11% | -$439.5K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,080 | 32.5K | +39% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +12.5K | 179.1K | +7% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $106.11 | -5,853 | 181.4K | -3% | -$621.1K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +4,888 | 27.6K | +22% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $106.11 | -2,230 | 26.1K | -8% | -$236.6K |
| D | 2025-02-18 | 2025-02-14 | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale+OE | $106.31 | -1,201 | 25.4K | -5% | -$127.7K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,689 | 51.2K | +10% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $106.11 | -2,269 | 50.7K | -4% | -$240.8K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $106.11 | -6,379 | 245.6K | -3% | -$676.9K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.2K | 249.8K | +6% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $106.11 | -4,080 | 19.4K | -17% | -$432.9K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +8,552 | 20.9K | +69% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $106.11 | -869 | 4,301 | -17% | -$92.2K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +1,964 | 4,584 | +75% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $105.77 | -530 | 25.5K | -2% | -$56.1K |
| D | 2025-02-14 | 2025-02-12 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +1,731 | 26.0K | +7% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $105.77 | -1,579 | 174.7K | -0.9% | -$167.0K |
| D | 2025-02-14 | 2025-02-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +3,462 | 176.3K | +2% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +3,654 | 245.1K | +2% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $105.77 | -1,767 | 243.3K | -0.7% | -$186.9K |
| D | 2025-02-14 | 2025-02-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +13.7K | 1.63M | +0.8% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $105.77 | -6,626 | 1.63M | -0.4% | -$700.8K |
| D | 2025-02-14 | 2025-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $105.77 | -231 | 3,206 | -7% | -$24.4K |
| D | 2025-02-14 | 2025-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +480 | 3,437 | +16% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,115 | 30.6K | +7% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $105.77 | -868 | 29.7K | -3% | -$91.8K |
| D | 2025-02-14 | 2025-02-12 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +2,692 | 18.7K | +17% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $105.77 | -950 | 17.8K | -5% | -$100.5K |
| D | 2025-02-14 | 2025-02-12 | BSX | O'Sullivan Miriam | SVP, Chief HR Off | F - Tax | $105.77 | -338 | 12.6K | -3% | -$35.8K |
| D | 2025-02-14 | 2025-02-12 | BSX | O'Sullivan Miriam | SVP, Chief HR Off | M - OptEx | $0.00 | +961 | 12.9K | +8% | $0 |
| DI | 2025-02-14 | 2025-02-12 | BSX | O'Sullivan Miriam | SVP, Chief HR Off | F - Tax | $105.77 | -23 | 1,544 | -1% | -$2,433 |
| DI | 2025-02-14 | 2025-02-12 | BSX | O'Sullivan Miriam | SVP, Chief HR Off | M - OptEx | $0.00 | +65 | 1,567 | +4% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,442 | 48.7K | +3% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $105.77 | -424 | 48.3K | -0.9% | -$44.8K |
| 2025-02-13 | 2025-02-11 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $105.98 | -62.9K | 1.62M | -4% | -$6.67M | |
| 2025-02-13 | 2025-02-11 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +130.1K | 1.68M | +8% | $0 | |
| 2025-02-13 | 2025-02-11 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | A - Grant | $0.00 | +20.4K | 25.9K | +370% | $0 | |
| 2025-02-13 | 2025-02-11 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $105.98 | -9,847 | 16.0K | -38% | -$1.04M | |
| 2025-02-13 | 2025-02-11 | BSX | Brown Vance R | SVP, GC, Corp. Sec | A - Grant | $0.00 | +14.7K | 53.6K | +38% | $0 | |
| 2025-02-13 | 2025-02-11 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $105.98 | -6,350 | 47.2K | -12% | -$673.0K | |
| 2025-02-13 | 2025-02-11 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $105.98 | -14.4K | 172.9K | -8% | -$1.53M | |
| 2025-02-13 | 2025-02-11 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +31.7K | 187.3K | +20% | $0 | |
| 2025-02-13 | 2024-12-10 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $89.97 | -20 | 148.1K | -0.0% | -$1,799 | |
| 2025-02-13 | 2024-12-03 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | P - Purchase | $90.29 | +50 | 148.2K | +0.0% | +$4,514 | |
| 2025-02-13 | 2025-02-12 | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale | $105.06 | -6,389 | 24.3K | -21% | -$671.2K | |
| 2025-02-13 | 2025-02-12 | BSX | Sorenson John Bradley | EVP, Gbl Ops | G - Gift | $0.00 | -2,156 | 30.7K | -7% | $0 | |
| 2025-02-13 | 2025-02-11 | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $105.98 | -3,793 | 32.8K | -10% | -$402.0K | |
| 2025-02-13 | 2025-02-11 | BSX | Sorenson John Bradley | EVP, Gbl Ops | A - Grant | $0.00 | +10.2K | 36.6K | +38% | $0 | |
| D | 2025-02-13 | 2025-02-11 | BSX | Brennan Daniel J. | EVP, CFO | A - Grant | $0.00 | +33.9K | 257.9K | +15% | $0 |
| D | 2025-02-13 | 2025-02-11 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $105.98 | -16.4K | 241.5K | -6% | -$1.74M |
| D | 2025-02-13 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $16.31 | +15.1K | 256.5K | +6% | +$246.1K |
| D | 2025-02-13 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.07 | -15.1K | 241.5K | -6% | -$1.59M |
| 2025-02-13 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.06 | -13.0K | 28.5K | -31% | -$1.37M |
Purchase Sale Sale after option exercise All abbreviations